Form 4 for BHC Bausch Health Companies Inc.
Accepted 2022-04-15 00:00:00 ET · period of report 2022-04-14 · accession 0001127602-22-012006 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-04-15 | 2022-04-14 | BHC | Spurr Robert | U.S. Pres-Pharma Business | S - Sale | $22.19 | -1,595 | 90.5K | -2% | -$35.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Shares, No Par Value | 2022-04-14 | S | D | 1,595 | $22.19 | 90,506 | D | — | — | (F1) The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 16, 2021. |